Skip to main content

Staccato Alprazolam as rescue medication for adolescents with epilepsy

Research Question:
What is the safety profile of a single dose of Staccato Alprazolam in adolescents with epilepsy?

Basic Study Information

After a screening visit, subjects between the age of 12-17 would be admitted to the Clinical Research Center for 36 hours. During their admission, they would receive a single dose of alprazolam by inhaling the medication into their lungs. They would be observed for 36 hours with 6 sets of vital signs and blood draws. Eligibility: Adolescents with epilepsy (either focal and/or generalized), ages 12-17, who weigh below 110 lbs and who are in generally good health. Potential subjects must currently be taking at least one medication for their epilepsy.

Location: University of Rochester Medical Center - Strong Memorial Hospital
Study Reference #: 6200

Lead Researcher (Principal Investigator)

Lead Researcher:  Thomas Wychowski

Study Contact Information

Study Coordinator: Cate Concannon
Phone: (585) 275-0404

Additional Study Details

Number of Visits:  2 to 5
Parking:  Reimbursed
Transportation Coverage:  Yes
Reimbursement:  Yes

Learn More About These Conditions

More information about Epilepsy

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search